The same rep is going to the hospital selling multiple product lines. And that has its efficiency to it in a significant way with more territories, less travel.

Nov 14, 2023 / receipt, needs a key / Larry, CEO | earnings call 2023-11-14 | transcript beb1f861-9f8b-4417-b049-e9fc18522bf5 | chars 32877-33037 | segment 33

Salary and marketing expenses increased 0.2 million, or 7%, primarily due to higher consulting fees associated with CMS reimbursement-related activity and trade show expenses.

Aug 11, 2023 / receipt, needs a key / Mike Wallace, CFO | earnings call 2023-08-11 | transcript da041d5c-163b-4fa5-8da3-976f32746c93 | chars 10672-10847 | segment 11

Selling and marketing expenses increased $0.3 million, or 14%, primarily due to higher consulting fees associated with CMS reimbursement-related activity and travel expenses.

May 11, 2023 / receipt, needs a key / Mike Lawless, CFO | earnings call 2023-05-11 | transcript 0f6d8307-a1be-4b2e-bac8-c08ec5b86c67 | chars 13376-13550 | segment 14

Selling and marketing expenses increased to $0.3 million, or 14%, primarily due to higher consulting fees associated with CMS reimbursement-related activity and travel expenses.

May 11, 2023 / receipt, needs a key / Mike, other | earnings call 2023-05-11 | transcript 0f6d8307-a1be-4b2e-bac8-c08ec5b86c67 | chars 55490-55667 | segment 57

In selling and marketing, spending increased 0.8 million, or 44%, primarily due to higher consulting fees associated with the CMS reimbursement progress and greater commercial activity as COVID-related restrictions are lifted, including trade show, travel, and personnel-related expenses.

Feb 23, 2023 / receipt, needs a key / Larry Jasinski, CEO | earnings call 2023-02-23 | transcript 182be31f-a1c2-4cf4-8fb5-3102084689a9 | chars 10610-10898 | segment 10

Our third quarter of 2022 operating expenses 5.7 million as compared to 3.8 million in the prior year's quarter. Within R&D, this increase is attributable to higher consultants' activity on development projects, partially offset by some grant assistance from the Israel Innovation Authority. In sales and marketing, we also had an increase in spending, primarily due to higher consulting expenses related to CMS progress, sales-related expenditures for trade show activities since the COVID restrictions are being lifted, and personnel-related costs. General and administrative expenses also grew primarily from higher professional services associated with the expanded 2022 proxy process.

Nov 7, 2022 / receipt, needs a key / Mike Lawless, CFO | earnings call 2022-11-07 | transcript 28127639-a560-44b7-910a-f632c2db937b | chars 8126-8815 | segment 8

During a year when the pandemic continued longer than expected and the significant spike in the fourth quarter with the Omnicon variant, The company grew revenue for the year ended December 31st, 2021 to 5.97 million, a 36% increase year over year. We had 1.24 million in Q4 sales, which was a 2% increase over the prior year quarter. During 2021, the COVID-19 pandemic continued to impact our sales activities. Three key factors were one, Reduction in incoming leads over much of 2021 as trade shows and in-person demonstrations were very limited by COVID-19 restrictions. Two, our inability to train patients as many clinics remain closed, which prevented the six months plus cycle of moving patients through the system for Q4 conversion due to the ongoing pandemic. And three, further limitation of conversion of the trainings that were achieved to date due to the Omicron variant spike in Q4.

Feb 24, 2022 / receipt, needs a key / Larry Jasinski, CEO | earnings call 2022-02-24 | transcript 032ffd8d-a0ce-4c3f-951b-027ede529917 | chars 3209-4105 | segment 3

Our operating expenses will be level in almost all efforts beyond sales commission and travel expenses.

May 11, 2021 / receipt, needs a key / Larry Jasinski, CEO | earnings call 2021-05-11 | transcript 68946ba1-5b0e-4005-8deb-19627e97e653 | chars 5014-5117 | segment 5

Second, We expect in 2021 that total operating costs will be kept level other than some increases in travel and commissions with growing sales.

Feb 18, 2021 / receipt, needs a key / Larry, CEO | earnings call 2021-02-18 | transcript 35ccf49d-cc08-463b-95e6-6f2377e92ab6 | chars 14721-14864 | segment 15